Shouman Wang

机构：Central South University, Hunan Cancer Hospital, Jiangsu Province Hospital, Xiangya Hospital Central South University, Nanjing Medical University

发表论文 64 篇 · 总被引 834 次 · h-index 17

代表论文

• Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer (2024 · JAMA · 被引 49)
• Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial (2024 · Journal of Clinical Oncology · 被引 49)
• NSUN2–tRNAVal−CAC-axis-regulated codon-biased translation drives triple-negative breast cancer glycolysis and progression (2025 · Cellular & Molecular Biology Letters · 被引 19)
• METTL3-mediated m 6 A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis (2023 · Epigenetics · 被引 17)
• Research progress on the multi-omics and survival status of circulating tumor cells (2024 · Clinical and Experimental Medicine · 被引 13)
• Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial (2024 · Breast Cancer Research · 被引 12)